373 related articles for article (PubMed ID: 31492174)
21. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
22. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of NUT carcinoma of lung origin by next-generation sequencing: case report and review of the literature.
Mao N; Liao Z; Wu J; Liang K; Wang S; Qin S; Dou Y; Lin H; Dong X
Cancer Biol Ther; 2019; 20(2):150-156. PubMed ID: 30307375
[TBL] [Abstract][Full Text] [Related]
24. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
[TBL] [Abstract][Full Text] [Related]
25. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
26. NUT Carcinoma of the Sublingual Gland.
Andreasen S; French CA; Josiassen M; Hahn CH; Kiss K
Head Neck Pathol; 2016 Sep; 10(3):362-6. PubMed ID: 26586234
[TBL] [Abstract][Full Text] [Related]
27. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
28. NUT carcinoma in a nutshell: A diagnosis to be considered more frequently.
Albrecht T; Harms A; Roessler S; Goeppert B
Pathol Res Pract; 2019 Jun; 215(6):152347. PubMed ID: 30782401
[TBL] [Abstract][Full Text] [Related]
29. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
[TBL] [Abstract][Full Text] [Related]
30. Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature.
Raza A; Cao H; Conrad R; Cobb C; Castelino-Prabhu S; Mirshahidi S; Shiraz P; Mirshahidi HR
Expert Rev Anticancer Ther; 2015; 15(10):1199-213. PubMed ID: 26402248
[TBL] [Abstract][Full Text] [Related]
31. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract][Full Text] [Related]
32. Cytologic findings of NUT midline carcinoma in the hilum of the lung.
Policarpio-Nicolas ML; de Leon EM; Jagirdar J
Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
Shah A; Box A; Brenn T; Flaman A
J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
[TBL] [Abstract][Full Text] [Related]
34. NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin.
Tanaka M; Kato K; Gomi K; Yoshida M; Niwa T; Aida N; Kigasawa H; Ohama Y; Tanaka Y
Am J Surg Pathol; 2012 Mar; 36(3):381-8. PubMed ID: 22301500
[TBL] [Abstract][Full Text] [Related]
35. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
Bishop JA; French CA; Ali SZ
Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of nuclear protein in testis (NUT) midline carcinoma in the upper aerodigestive tract and mediastinum.
Solomon LW; Magliocca KR; Cohen C; Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Feb; 119(2):213-20. PubMed ID: 25434692
[TBL] [Abstract][Full Text] [Related]
38. Demystified molecular pathology of NUT midline carcinomas.
French CA
J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174
[TBL] [Abstract][Full Text] [Related]
39. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
[TBL] [Abstract][Full Text] [Related]
40. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
